THURSDAY, May 11, 2023 (HealthDay News) — A medication to treat agitation in Alzheimer’s patients now has approval from the U.S. Food and Drug Administration. The FDA gave supplemental approval to Otsuka Pharmaceutical Company Ltd., and Lundbeck Inc. for Rexulti (brexpiprazole) oral tablets on Thursday. Rexulti is the first FDA-approvedContinue Reading

THURSDAY, May 11, 2023 (HealthDay News) — People who use a Peloton exercise bike at home should check their model number immediately. A recall of 2 million bikes with the model number PL01 was issued Thursday. People should stop using them immediately because of fall and injury hazards, the U.S.Continue Reading